Andreja Emeršič

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

Juan Lantero‐Rodriguez, Thomas K. Karikari, Marc Suárez‐Calvet et al. · Acta Neuropathologica · 2020 · 378 citations · Full text

Medicine, Neurology, Neuroscience +17

Diagnostic and prognostic value of serum NfL and p-Tau₁₈₁in frontotemporal lobar degeneration

Alberto Benussi, Thomas K. Karikari, Nicholas J. Ashton et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 162 citations

Medicine, Neurology, Neuroscience +17

Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis

Thomas K. Karikari, Andreja Emeršič, Agathe Vrillon et al. · Alzheimer s & Dementia · 2020 · 158 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration

Alberto Benussi, Nicholas J. Ashton, Thomas K. Karikari et al. · Journal of Alzheimer s Disease · 2020 · 116 citations · Full text

Medicine, Neurology, Neuroscience +17

N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases

Anniina Snellman, Juan Lantero‐Rodriguez, Andreja Emeršič et al. · Brain · 2021 · 50 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17